STATERA BIOPHARMA, INC.

Profile

Company Names

STATERA BIOPHARMA, INC.
CLEVELAND BIOLABS INC

Addresses

4333 CORBETT DRIVE, SUITE 1082, FORT COLLINS, CO 80525

73 HIGH STREET, BUFFALO, NY 14203

Phone Numbers

(888) 613-8802
(716) 849-6810

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$40,531,976.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2022-11-01 
$577,000.00 
$764,500.00 
$187,500.00 
Equity 
6
2020-06-03 
$1,588,262.00 
$1,588,262.00 
$0.00 
Equity 
5
2015-12-18 
$1,140,157.00 
$1,140,157.00 
$0.00 
Equity 
4
2015-07-09 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
3
2014-06-20 
$3,500,000.00 
$3,500,000.00 
$0.00 
Equity 
2
2010-03-02 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2009-03-20 
$3,726,557.00 
$3,726,557.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALEXANDER 
 
ANDRYUSHECHKIN 
DIRECTOR
JAMES 
 
ANTAL 
DIRECTOR
JAMES 
ANTAL 
DIRECTOR
JAMES 
J. 
ANTAL 
DIRECTOR
JULIA 
R. 
BROWN 
DIRECTOR
ROBERT 
 
BUCKHEIT 
EXECUTIVE OFFICER
SATISH 
 
CHANDREN 
DIRECTOR
PAUL 
 
DICORLETO 
DIRECTOR
ANNA 
 
EVDOKIMOVA 
DIRECTOR
IVAN 
 
FEDYUNIN 
DIRECTOR
MICHAEL 
 
FONSTEIN 
EXECUTIVE OFFICER, DIRECTOR
KONSTANTIN 
 
GORSHKOV 
DIRECTOR
KONSTANTINIE 
 
GORSHKOV 
DIRECTOR
ANDREI 
 
GUDKOV 
EXECUTIVE OFFICER, DIRECTOR
ANDREI 
 
GUDKOV, PH.D., D., SCI. 
EXECUTIVE OFFICER
MICHAEL 
KEVIN 
HANDLEY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BLAKE 
 
HAWLEY 
DIRECTOR
DANIEL 
F. 
HOTH 
DIRECTOR
BERNARD 
 
KASTEN 
DIRECTOR
BERNARD 
L. 
KASTEN 
DIRECTOR
NATALIA 
 
KHUDYK 
DIRECTOR
YAKOV 
 
KOGAN 
EXECUTIVE OFFICER, DIRECTOR
YULIA 
 
LEBEDINA 
DIRECTOR
TATIANA 
 
LEVINA 
DIRECTOR
NEIL 
LYONS 
EXECUTIVE OFFICER
C. 
NEIL 
LYONS 
EXECUTIVE OFFICER
JACK 
 
MARHOFER 
EXECUTIVE OFFICER
JOHN 
 
MARHOFER 
EXECUTIVE OFFICER
RICHARD 
MCGOWAN 
DIRECTOR
RICHARD 
S. 
MCGOWAN 
DIRECTOR
LANGDON 
 
MILLER 
EXECUTIVE OFFICER
LANGDON 
 
MILLER, MD 
EXECUTIVE OFFICER
IVAN 
 
PERSIYANOV 
DIRECTOR
ALEXANDER 
 
POLINSKY 
DIRECTOR
ANTHONY 
PRINCIPI 
DIRECTOR
ANTHONY 
J. 
PRINCIPI 
DIRECTOR
RANDY 
SALUCK 
DIRECTOR
RANDY 
S. 
SALUCK 
DIRECTOR
NATALIA 
 
SARAEVA 
DIRECTOR
UDAY 
 
SAXENA 
DIRECTOR
DANIIL 
 
TALYANSKIY 
DIRECTOR
LEA 
 
VERNY 
DIRECTOR
CHRISTOPHER 
 
ZOSH 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2022-11-01 
D
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2020-06-03 
D
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2015-12-18 
D
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2015-07-09 
D
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2014-06-20 
D
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2010-03-02 
D
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
 
2009-03-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
LADENBURG + THALMANN + CO., INC.
505
NONE
NONE
H.C.WAINWRIGHT + CO., LLC
375
RODMAN + RENSHAW, LLC
RODMAN + RENSHAW, LLC
GARDEN STATE SECURITIES, INC.
GARDEN STATE SECURITIES, INC.